Abstract

Cellular heterogeneity underlies cancer evolution and metastasis. Advances in single-cell technologies such as single-cell RNA sequencing and mass cytometry have enabled interrogation of cell type-specific expression profiles and abundance across heterogeneous cancer samples obtained from clinical trials and preclinical studies. However, challenges remain in determining sample sizes needed for ascertaining changes in cell type abundances in a controlled study. To address this statistical challenge, we have developed a new approach, named Sensei, to determine the number of samples and the number of cells that are required to ascertain such changes between two groups of samples in single-cell studies. Sensei expands the t-test and models the cell abundances using a beta-binomial distribution. We evaluate the mathematical accuracy of Sensei and provide practical guidelines on over 20 cell types in over 30 cancer types based on knowledge acquired from the cancer cell atlas (TCGA) and prior single-cell studies. We provide a web application to enable user-friendly study design via https://kchen-lab.github.io/sensei/table_beta.html.

Highlights

  • Cellular composition varies across different tissues and organs of the human body [1]

  • Our results show that compared with the primary tumors, a change in monocyte proportion in the recurrent tumors may be detected in low grade glioma (LGG) with a modest samples size of 34 (Fig. 3b)

  • Using the cell type abundance deconvolved from the bulk RNA expression data [2] and the microsatellite instability labels obtained from genomic testing [45], we summarized the immune cell type abundance for the three cancer types (Additional file 1: Figure S8b)

Read more

Summary

Introduction

Cellular composition varies across different tissues and organs of the human body [1]. Cell type abundance is highly dynamic and varies across physiological and pathological states, including oncogenesis [2,3,4] These changes in cell composition may be subtle and their detection requires the use of single-cell technologies coupled with accurate analytical pipelines allowing the enumeration of cell populations-of-interest with adequate specificity, especially for rare cell types [5]. Ascertainment of these changes is critical to understand the complexity of human diseases. Observing temporal dynamics within the immune cell compartment is critical to understand processes such as autoimmunity [6, 9, 10], susceptibility to infections [6, 8], and development of cancers [3, 4, 6]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.